Warning letter faults Akorn management for plant failures

10th July 2019 Uncategorised 0

Two weeks ago, the FDA slapped Akorn’s New Jersey sterile injectables plant with a warning letter, but CEO Douglas Boothe said he remained confident about the quality of its products. Unfortunately for the company, the FDA doesn’t feel the same way. 

More: Warning letter faults Akorn management for plant failures
Source: fierce